Clinical Trials Logo

Clinical Trial Summary

Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.


Clinical Trial Description

this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03068702
Study type Observational
Source Dr. S.S. Michel Clinic
Contact
Status Completed
Phase N/A
Start date August 21, 2016
Completion date February 21, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT06396403 - The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy